Mark Yarchoan

Assistant Professor

20112019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Mark Yarchoan is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 1 Similar Profiles
Alzheimer Disease Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Proto-Oncogene Proteins B-raf Medicine & Life Sciences
Immunotherapy Medicine & Life Sciences
Tumor Burden Medicine & Life Sciences
Thyroid Neoplasms Medicine & Life Sciences
Adenocarcinoma Medicine & Life Sciences
Pancreatic Neoplasms Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2011 2019

Clinical and laboratory features of autoimmune hemolytic anemia associated with immune checkpoint inhibitors

Leaf, R. K., Ferreri, C., Rangachari, D., Mier, J., Witteles, W., Ansstas, G., Anagnostou, T., Zubiri, L., Piotrowska, Z., Oo, T. H., Iberri, D., Yarchoan, M., Salama, A. K. S., Johnson, D. B., Leavitt, A. D., Rahma, O. E., Reynolds, K. L. & Leaf, D. E., Jan 1 2019, In : American journal of hematology.

Research output: Contribution to journalArticle

Autoimmune Hemolytic Anemia
Coombs Test
Glucocorticoids
Hemoglobins
Preexisting Condition Coverage

Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic

Chan, T. A., Yarchoan, M., Jaffee, E., Swanton, C., Quezada, S. A., Stenzinger, A. & Peters, S., Jan 1 2019, In : Annals of oncology : official journal of the European Society for Medical Oncology. 30, 1, p. 44-56 13 p.

Research output: Contribution to journalArticle

Tumor Burden
Immunotherapy
Biomarkers
Mutation
Ligands

Immune-related adverse events requiring hospitalization: Spectrum of toxicity, treatment, and outcomes

Balaji, A., Zhang, J., Wills, B., Marrone, K., Elmariah, H., Yarchoan, M., Zimmerman, J. W., Hajjir, K., Venkatraman, D., Armstrong, D. K., Laheru, D., Mehra, R., Ho, W. J., Reuss, J. E., Heng, J., Vellanki, P., Donehower, R. C., Holdhoff, M. & Naidoo, J., Jan 1 2019, In : Journal of oncology practice. 15, 9, p. E825-E834

Research output: Contribution to journalArticle

Hospitalization
Gastroenterology
Immunotherapy
Inpatients
Referral and Consultation

Mechanistically detailed systems biology modeling of the HGF/Met pathway in hepatocellular carcinoma

Jafarnejad, M., Sové, R. J., Danilova, L. V., Mirando, A. C., Zhang, Y., Yarchoan, M., Tran, P. T., Pandey, N., Fertig, E. & Popel, A. S., Dec 1 2019, In : npj Systems Biology and Applications. 5, 1, 29.

Research output: Contribution to journalArticle

Open Access
Integrin
Systems Biology
Hepatocyte Growth Factor
Growth Factors
Integrins

Multiple immune-suppressive mechanisms in fibrolamellar carcinoma

Kim, A., Gani, F., Layman, A. J., Besharati, S., Zhu, Q., Succaria, F., Engle, E. L., Bhaijee, F., Goggins, M. B., Llosa, N., Pawlik, T. M., Yarchoan, M., Jaffee, E., Simons, H. C., Taube, J. M. & Anders, R. A., May 1 2019, In : Cancer Immunology Research. 7, 5, p. 805-812 8 p.

Research output: Contribution to journalArticle

Carcinoma
Neoplasms
Tumor-Infiltrating Lymphocytes
Cytotoxic T-Lymphocytes
Myeloid Cells